|
KLF11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.561100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.903580E-01 |
| Normal-vs-Stage2 |
2.316200E-03 |
| Normal-vs-Stage3 |
8.23349999999889E-05 |
| Normal-vs-Stage4 |
4.5706000095791E-09 |
| Stage1-vs-Stage2 |
3.234300E-02 |
| Stage1-vs-Stage3 |
1.121590E-03 |
| Stage1-vs-Stage4 |
1.48419999623783E-08 |
| Stage2-vs-Stage3 |
7.734800E-01 |
| Stage2-vs-Stage4 |
3.198300E-02 |
| Stage3-vs-Stage4 |
3.252000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.058830E-03 |
| Normal-vs-AfricanAmerican |
2.13879999999556E-05 |
| Normal-vs-Asian |
9.309400E-01 |
| Caucasian-vs-AfricanAmerican |
4.078000E-02 |
| Caucasian-vs-Asian |
3.771400E-01 |
| AfricanAmerican-vs-Asian |
7.346400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.54670000000112E-05 |
| Normal-vs-Female |
8.759700E-02 |
| Male-vs-Female |
9.635000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.547640E-02 |
| Normal-vs-Age(41-60Yrs) |
4.658300E-03 |
| Normal-vs-Age(61-80Yrs) |
4.752800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.396590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.979400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.305600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.604600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.250000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.178000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.231400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.606600E-01 |
| Normal-vs-Grade 2 |
3.608600E-01 |
| Normal-vs-Grade 3 |
1.410290E-04 |
| Normal-vs-Grade 4 |
3.68239994052999E-10 |
| Grade 1-vs-Grade 2 |
5.359000E-01 |
| Grade 1-vs-Grade 3 |
3.395900E-02 |
| Grade 1-vs-Grade 4 |
2.026400E-04 |
| Grade 2-vs-Grade 3 |
1.175020E-04 |
| Grade 2-vs-Grade 4 |
2.92379997990366E-09 |
| Grade 3-vs-Grade 4 |
6.614800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.518600E-01 |
| Normal-vs-ccB subtype |
4.02950000033542E-08 |
| ccA subtype-vs-ccB subtype |
2.77555756156289E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.278150E-03 |
| Normal-vs-N1 |
2.576200E-04 |
| N0-vs-N1 |
6.653700E-02 |
|
|
